KAZUHIRO OKA to Genetic Therapy
This is a "connection" page, showing publications KAZUHIRO OKA has written about Genetic Therapy.
Connection Strength
2.102
-
Gene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector. Gene Ther. 2015 Jan; 22(1):87-95.
Score: 0.316
-
Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther. 2007 Feb; 14(3):191-202.
Score: 0.181
-
Targeting site-specific chromosome integration. Acta Biochim Pol. 2005; 52(2):285-91.
Score: 0.166
-
Inhibition and regression of atherosclerotic lesions. Acta Biochim Pol. 2005; 52(2):311-9.
Score: 0.166
-
Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy. Methods Mol Med. 2005; 108:329-50.
Score: 0.161
-
Liver-directed gene therapy for dyslipidemia and diabetes. Curr Atheroscler Rep. 2004 May; 6(3):203-9.
Score: 0.154
-
Recent advances in liver-directed gene therapy for dyslipidemia. Curr Atheroscler Rep. 2002 May; 4(3):199-207.
Score: 0.134
-
Recent advances in liver-directed gene therapy: implications for the treatment of dyslipidemia. Curr Opin Lipidol. 2000 Apr; 11(2):179-86.
Score: 0.116
-
Adeno-Associated Virus as Gene Delivery Vehicle into the Retina. Methods Mol Biol. 2020; 2092:77-90.
Score: 0.114
-
Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice. Gene Ther. 2015 Nov; 22(11):876-82.
Score: 0.084
-
Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice. PLoS One. 2015; 10(6):e0128996.
Score: 0.083
-
Gene therapy for neuropathic pain by silencing of TNF-a expression with lentiviral vectors targeting the dorsal root ganglion in mice. PLoS One. 2014; 9(3):e92073.
Score: 0.076
-
Neo-islet formation in liver of diabetic mice by helper-dependent adenoviral vector-mediated gene transfer. J Vis Exp. 2012 Oct 10; (68).
Score: 0.069
-
DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice. J Clin Invest. 2009 Jul; 119(7):2100-112.
Score: 0.055
-
Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model. Mol Ther. 2008 11; 16(11):1805-12.
Score: 0.052
-
Regulatable atrial natriuretic peptide gene therapy for hypertension. Proc Natl Acad Sci U S A. 2005 Sep 27; 102(39):13789-94.
Score: 0.042
-
Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene Ther. 2004 Oct; 11(20):1540-8.
Score: 0.040
-
Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation. 2003 Jun 03; 107(21):2726-32.
Score: 0.036
-
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A. 2001 Nov 06; 98(23):13282-7.
Score: 0.032
-
Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem. 1996 Mar 22; 271(12):6852-60.
Score: 0.022